- 专利标题： Compounds as inhibitors of hepatitis C virus NS3 serine protease
-
申请号： US11065509申请日： 2005-02-24
-
公开(公告)号： US07192957B2公开(公告)日： 2007-03-20
- 发明人: Srikanth Venkatraman , F. George Njoroge , Melissa L. Blackman , Wanli Wu , Latha G. Nair , Ashok Arasappan , Stephane L. Bogen , Kevin X. Chen , Mousumi Sannigrahi , Frank Bennett , Viyyoor M. Girijavallabhan
- 申请人： Srikanth Venkatraman , F. George Njoroge , Melissa L. Blackman , Wanli Wu , Latha G. Nair , Ashok Arasappan , Stephane L. Bogen , Kevin X. Chen , Mousumi Sannigrahi , Frank Bennett , Viyyoor M. Girijavallabhan
- 申请人地址： US NJ Kenilworth
- 专利权人： Schering Corporation
- 当前专利权人： Schering Corporation
- 当前专利权人地址： US NJ Kenilworth
- 代理商 Palaiyur S. Kalyanaraman; Serena Farquharson-Torres
- 主分类号： A61K31/4035
- IPC分类号： A61K31/4035 ; A61K31/454 ; A61K31/5377 ; A61K31/4439 ; A61K31/4402 ; C07D413/12 ; C07D401/12 ; C07D209/54
摘要：
The present invention discloses novel compounds which have HCV protease inhibitory activity as well as methods for preparing such compounds. In another embodiment, the invention discloses pharmaceutical compositions comprising such compounds as well as methods of using them to treat disorders associated with the HCV protease.